Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
POPI
1 other identifier
interventional
2,531
1 country
1
Brief Summary
Chlamydial infection is a common, sexually transmitted disease which women can have without knowing. Untreated, it can lead to an infection of the womb and fallopian tubes called pelvic inflammatory disease (PID), which can cause infertility. There has been only one trial of chlamydia screening and this was in American women in 1992 and used outdated tests. We now need to see if screening using modern tests and self-taken swabs works in a high risk, young, multiethnic female population in the United Kingdom (UK). The study is a randomised trial. It will involve asking women students in college bars to complete confidential questionnaires on sexual health and to provide self-administered vaginal swabs. We have successfully done this in a small pilot study. Participants will be told that the tests are for research purposes only and that if they think they may have been at risk of a sexually transmitted infection they should get checked at a clinic. If the trial shows that chlamydia screening using these new methods prevents PID, extending this community-based intervention nationwide could improve women's reproductive health and wellbeing and might prevent some women from becoming infertile
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2004
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2004
CompletedFirst Submitted
Initial submission to the registry
June 21, 2005
CompletedFirst Posted
Study publicly available on registry
June 22, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedNovember 24, 2014
November 1, 2014
4.3 years
June 21, 2005
November 21, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome measure in the complete cohort: Incidence of clinical PID over 12 months in intervention and control groups.
12 months
Secondary Outcomes (6)
Secondary outcome measures after 12 months in women with chlamydial infection at baseline:
12 months
Control group (untreated):
12 months
Incidence of PID.
12 months
Percentage with spontaneous clearance of genital infection.
12 months
Relative risk of PID in women with and without BV
12 months
- +1 more secondary outcomes
Study Arms (1)
Deferred screening control group
OTHERSamples from women in the control group were stored and tested at the end of the trial
Interventions
Women in the intervention group will be tested for chlamydia and those found to be infected will be referred for treatment and partner notification
Eligibility Criteria
You may qualify if:
- Sexually active
You may not qualify if:
- Never been sexually active
- Tested for chlamydia in past 3 months and no new sexual partner since then
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St George's Hospital Medical School
London, Sw17 ORE, United Kingdom
Related Publications (4)
Hay PE, Kerry SR, Normansell R, Horner PJ, Reid F, Kerry SM, Prime K, Williams E, Simms I, Aghaizu A, Jensen J, Oakeshott P. Which sexually active young female students are most at risk of pelvic inflammatory disease? A prospective study. Sex Transm Infect. 2016 Feb;92(1):63-6. doi: 10.1136/sextrans-2015-052063. Epub 2015 Jun 16.
PMID: 26082320DERIVEDOakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, Simms I, Hay P. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010 Apr 8;340:c1642. doi: 10.1136/bmj.c1642.
PMID: 20378636DERIVEDOakeshott P, Kerry S, Atherton H, Aghaizu A, Hay S, Taylor-Robinson D, Simms I, Hay P. Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. Trials. 2008 Dec 10;9:73. doi: 10.1186/1745-6215-9-73.
PMID: 19077198DERIVEDAtherton H, Banks D, Harbit R, Long L, Chadd F, Hay P, Kerry S, Simms I, Oakeshott P. Recruitment of young women to a trial of chlamydia screening - as easy as it sounds? Trials. 2007 Dec 4;8:41. doi: 10.1186/1745-6215-8-41.
PMID: 18053199DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pippa Oakeshott, MD FRCP
St George's, University of London
- STUDY CHAIR
Phillip Hay, FRCP
St George's, University of London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of General Practice
Study Record Dates
First Submitted
June 21, 2005
First Posted
June 22, 2005
Study Start
September 1, 2004
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
November 24, 2014
Record last verified: 2014-11